Contraceptive News and Research

RSS

Stiff competition for Viagra in the pipeline

Scientists in Scotland are in the process of developing a drug which could offer stiff competition to the drug Viagra.

20 May 2008

Traffic pollution can be deadly as it increases the risk of deep vein thrombosis

Scientists in the U.S. have confirmed a long held suspicion that traffic pollution can be deadly for some people.

13 May 2008

Breastfeeding may protect women from rheumatoid arthritis

Swedish researchers have found in a study on rheumatoid arthritis that breastfeeding protects women from the disease.

13 May 2008

Starpharma reports positive VivaGel clinical study results

Starpharma Holdings Limited today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel) was safe and well-tolerated in sexually abstinent women when administered vaginally, twice daily for 14 days.

11 May 2008

Barr announces approval of generic version of Yasmin (drospirenone and ethinyl estradiol)

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) to manufacture and market a generic version of Yasmin (drospirenone and ethinyl estradiol), an oral contraceptive product manufactured and marketed by Bayer Schering Pharma, AG.

9 May 2008

Better-educated women have healthier average weight

A new comparison of multi-national data, released this month, reveals that highly educated women have a healthier average weight than less educated women, but that the meaning of "healthier" changes according to a nation's relative wealth. In countries where malnutrition is prevalent, better-educated women weigh more. But in wealthier countries - with rapidly growing rates of obesity - better-educated women weigh less.

30 Apr 2008

Progesterone could prevent brain damage after head injury

A common component of the contraceptive pill (progesterone) could improve the neurologic outcome for patients with severe head injuries, according to a study published in BioMed Central's open access journal Critical Care.

30 Apr 2008

Connecticut HIV/AIDS advocates, teenagers call for passage of bill that would provide grants for comprehensive sex education

HIV/AIDS advocates and teenagers from Healthy Teens Connecticut on Wednesday in Connecticut rallied at the state capitol and called on lawmakers to pass a bill that would provide $500,000 in state grants for comprehensive sex education, the Hartford Courant reports.

26 Apr 2008

Hirsutism in premenopausal women - new treatment guidelines

The Endocrine Society has released new clinical practice guidelines for the treatment of hirsutism in premenopausal women. The guidelines appear in the April issue of the Journal of Clinical Endocrinology & Metabolism (JCEM), a publication of The Endocrine Society.

22 Apr 2008

Jamaica to launch new female condom as part of HIV/AIDS prevention efforts

Jamaica's National Family Planning Board in the next few weeks plans to launch a new female condom in an effort to provide women with increased control over HIV/AIDS prevention methods, the Jamaica Gleaner reports.

22 Apr 2008

Mayor of Aboriginal community knew of underage girls given contraceptive implants

Claims by the State Opposition that doctors have given contraceptive implants to girls without their parents' permission have been to some extent supported by the leader of a central Queensland Aboriginal community.

17 Apr 2008

Claim that contraceptive implants are given to underage aboriginal girls rejected

Queensland Health has rejected accusations that GPs are giving contraceptive implants to young girls without parental consent.

16 Apr 2008

Continuous oral contraceptives better at easing pain, bleeding

Continuous oral contraceptives may be more effective than the standard 28-day birth control pills in suppressing the ovary, according to researchers.

4 Apr 2008

Hormonal contraception for men

Hormonal contraception may become a safe, effective, and reversible form of birth control for men, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).

26 Mar 2008

Standard low-dose birth control pill can actually help women conceive

Women who have tried to conceive using in vitro fertilization (IVF) methods are painfully aware that timing is of the essence.

25 Mar 2008

New Hopkins report on successful health communication

Communication plays a crucial role in successful family planning, HIV prevention, and other health and development programs. Communication often is thought of as the production of messages and materials, such as postures or brochures. But effective communication programs that motivate people to adopt healthy behaviors and lifestyles use a systematic process and require long-term commitment.

21 Mar 2008

New choices bring wider range of women to family planning

A study appearing in the March 2008 issue of the journal Contraception reports that the Standard Days Method, a natural family planning method developed by researchers from Georgetown University Medical Center's Institute for Reproductive Health, brings new women to family planning.

19 Mar 2008

Watson Pharmaceuticals files application for generic LYBREL

Watson Pharmaceuticals, Inc. has confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its Levonorgestrel and Ethinyl Estradiol tablets, USP (0.09 mg/0.02 mg) extended-cycle oral contraceptive product prior to the expiration of patents owned by Wyeth.

14 Mar 2008

Home test kit confirms men's post-vasectomy sterility

Technology developed at the University of Virginia could soon have a dramatic impact on male contraception practices throughout the U.S. Earlier this year, the U.S. Food and Drug Administration approved SpermCheck Vasectomy, a home test that confirms men's post-vasectomy sterility and is based on discoveries made at U.Va.

12 Mar 2008

Long-term effects of synthetic progestins cause for concern

The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon.

11 Mar 2008